愛玩股
English
基本資料
相對強度
財報分析
成長能力
財務比率
現金流量
償債能力
成本分析
實用連結
雅虎財經
公司簡介
研究報告
在外流通股數
歷史市銷率
歷史本益比
盈餘估計修正
存貨周轉率
應收帳款周轉率
內部人交易
新聞
Corvus Pharmaceuticals Inc.
Stock
Quote (U.S. -
CRVS
CRVS
| Complete Corvus Pharmaceuticals Inc.
stock
news by MarketWatch. View real-time
stock
prices and
stock
quotes for a full financial overview.
Corvus Pharmaceuticals, Inc. Common
Stock
(
CRVS
) - Nasdaq
Discover real-time Corvus Pharmaceuticals, Inc. Common Stock (
CRVS
)
stock
prices, quotes, historical data, news, and Insights for informed trading and ...
CRVS
: Corvus Pharmaceuticals Inc -
Stock
Price, Quote and ...
Get Corvus Pharmaceuticals Inc (
CRVS
:NASDAQ) real-time
stock
quotes, news, price and financial information from CNBC.
Corvus Pharmaceuticals: Stockholder Overview
NASDAQ
CRVS
(Common
Stock
). $1.470 (0.00%). 04/16/24 4:00 PM EDT. Data Provided by Refinitiv. Minimum 15 minutes delayed. More. Recent News. Apr 09, 2024
CRVS
| Corvus Pharmaceuticals Inc.
Stock
Overview (U.S.
Complete Corvus Pharmaceuticals Inc. stock information by Barron's. View real-time
CRVS stock
price and news, along with industry-best analysis.
Corvus Pharmaceuticals (
CRVS
) 株価、見積もり - Stock Events
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies.
CRVS Stock
Quote Price and Forecast - CNN
View Corvus Pharmaceuticals, Inc.
CRVS stock
quote prices, financial information, real-time forecasts, and company news from CNN.
CRVS
| Corvus Pharmaceuticals Inc.
Stock
Price & News - WSJ
Key
Stock
Data · P/E Ratio (TTM). N/A · EPS (TTM).
$
-0.56 · Market Cap.
$
72.58 M · Shares Outstanding. 49.04 M · Public Float. 36.90 M · Yield.
CRVS
is not ...
免責聲明
本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。